Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for P61085

Entry ID Method Resolution Chain Position Source
2BEP X-ray 180 A A 1-155 PDB
2BF8 X-ray 230 A A 2-155 PDB
AF-P61085-F1 Predicted AlphaFoldDB

19 variants for P61085

Variant ID(s) Position Change Description Diseaes Association Provenance
rs468394793 2 A>G No EVA
rs436883855 3 N>D No EVA
rs450528999 4 I>N No EVA
rs464143927 6 V>G No EVA
rs432796283 10 K>N No EVA
rs452908935 12 E>G No EVA
rs473730370 13 F>V No EVA
rs435870844 16 V>G No EVA
rs451988006 64 E>G No EVA
rs467820686 173 G>A No EVA
rs467390410 180 I>K No EVA
rs436082117 181 V>G No EVA
rs449716609 184 S>F No EVA
rs469674416 189 D>E No EVA
rs431969287 192 T>A No EVA
rs451964616 192 T>S No EVA
rs435069781 194 T>I No EVA
rs475177316 195 E>V No EVA
rs457442061 199 S>R No EVA

No associated diseases with P61085

2 regional properties for P61085

Type Name Position InterPro Accession
domain Ubiquitin-conjugating enzyme E2 30 - 175 IPR000608
active_site Ubiquitin-conjugating enzyme, active site 103 - 118 IPR023313

Functions

Description
EC Number 2.3.2.23 Aminoacyltransferases
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
filopodium tip The end of a filopodium distal to the body of the cell.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

5 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ubiquitin conjugating enzyme activity Isoenergetic transfer of ubiquitin from one protein to another via the reaction X-ubiquitin + Y -> Y-ubiquitin + X, where both the X-ubiquitin and Y-ubiquitin linkages are thioester bonds between the C-terminal glycine of ubiquitin and a sulfhydryl side group of a cysteine residue.
ubiquitin protein ligase binding Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins.
ubiquitin-protein transferase activity Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.
ubiquitin-ubiquitin ligase activity Isoenergetic transfer of ubiquitin from one protein to an existing ubiquitin chain via the reaction X-ubiquitin + Y-ubiquitin -> Y-ubiquitin-ubiquitin + X, where both the X-ubiquitin and Y-ubiquitin-ubiquitin linkages are thioester bonds between the C-terminal glycine of ubiquitin and a sulfhydryl side group of a cysteine residue.

9 GO annotations of biological process

Name Definition
cellular response to interferon-beta Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-beta stimulus. Interferon-beta is a type I interferon.
free ubiquitin chain polymerization The process of creating free ubiquitin chains, compounds composed of a large number of ubiquitin monomers. These chains are not conjugated to a protein.
positive regulation of peptidyl-threonine phosphorylation Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
positive regulation of tumor necrosis factor-mediated signaling pathway Any process that activates or increases the frequency, rate or extent of tumor necrosis factor-mediated signaling pathway.
positive regulation of type I interferon-mediated signaling pathway Any process that increases the rate, frequency or extent of a type I interferon-mediated signaling pathway.
proteasome-mediated ubiquitin-dependent protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
protein K48-linked ubiquitination A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is added to a protein. K48-linked ubiquitination targets the substrate protein for degradation.
protein polyubiquitination Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain.
regulation of proteasomal ubiquitin-dependent protein catabolic process Any process that modulates the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.

8 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P21734 UBC1 Ubiquitin-conjugating enzyme E2 1 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q1RML1 UBE2S Ubiquitin-conjugating enzyme E2 S Bos taurus (Bovine) SS
Q32PA5 UBE2C Ubiquitin-conjugating enzyme E2 C Bos taurus (Bovine) PR
Q32LD2 UBE2T Ubiquitin-conjugating enzyme E2 T Bos taurus (Bovine) PR
Q32L27 UBE2Q2 Ubiquitin-conjugating enzyme E2 Q2 Bos taurus (Bovine) PR
P52486 Ubc4 Ubiquitin-conjugating enzyme E2-22 kDa Drosophila melanogaster (Fruit fly) PR
P61086 UBE2K Ubiquitin-conjugating enzyme E2 K Homo sapiens (Human) PR
P61087 Ube2k Ubiquitin-conjugating enzyme E2 K Mus musculus (Mouse) PR
10 20 30 40 50 60
MANIAVQRIK REFKEVLKSE ETSKNQIKVD LVDENFTELR GEIAGPPDTP YEGGRYQLEI
70 80 90 100 110 120
KIPETYPFNP PKVRFITKIW HPNISSVTGA ICLDILKDQW AAAMTLRTVL LSLQALLAAA
130 140 150 160 170 180
EPDDPQDAVV ANQYKQNPEM FKQTARLWAH VYAGAPVSSP EYTKKIENLC AMGFDRNAVI
190
VALSSKSWDV ETATELLLSN